[TLX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
30-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -45.27%
YoY- -51.95%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 CAGR
Revenue 24,047 4,686 2,910 3,606 1,607 1,667 1,818 136.30%
PBT -70,703 -61,993 -37,046 -35,157 -25,096 -25,690 -17,125 60.35%
Tax 188 -13,997 -4,532 -8,571 -6,795 -8,192 -6,756 -
NP -70,891 -47,996 -32,514 -26,586 -18,301 -17,497 -10,370 89.67%
Tax Rate - - - - - - - -
Total Cost 94,938 52,682 35,424 30,192 19,908 19,165 12,187 98.11%
Ratio Analysis
30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 CAGR
NP Margin -294.80 -1,024.24 -1,117.32 -737.27 -1,138.83 -1,049.33 -570.54 -19.73%
Per Share
30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 CAGR
EPS -0.23 -0.17 -0.12 -0.10 -0.07 -0.07 -0.05 66.23%
EPS Diluted -0.23 -0.17 -0.12 -0.10 -0.07 -0.07 -0.05 66.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.